RYDAPT Trademark

Trademark Overview

On Wednesday, June 4, 2014, a trademark application was filed for RYDAPT with the United States Patent and Trademark Office. The USPTO has given the RYDAPT trademark a serial number of 79149774. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, June 9, 2021. This trademark is owned by Novartis AG. The RYDAPT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular and metabolic system including diabetes, the respiratory system, the genitourinary system, for musculo-skeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, and in transplantation; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of ocular disorders; anti-infective preparations, antibiotics, antibacterial, antiviral and anti-fungal preparations, vaccines, pharmaceutical preparations for diagnostic use for medical purposes
rydapt

General Information

Serial Number79149774
Word MarkRYDAPT
Filing DateWednesday, June 4, 2014
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, June 9, 2021
Registration Number4710118
Registration DateTuesday, March 31, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 13, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular and metabolic system including diabetes, the respiratory system, the genitourinary system, for musculo-skeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, and in transplantation; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of ocular disorders; anti-infective preparations, antibiotics, antibacterial, antiviral and anti-fungal preparations, vaccines, pharmaceutical preparations for diagnostic use for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, March 31, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, June 9, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, June 9, 2021REGISTERED-SEC.71 ACCEPTED
Thursday, January 21, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 11, 2020TEAS SECTION 71 RECEIVED
Tuesday, March 31, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, September 14, 2017INTERNATIONAL REGISTRATION RENEWED
Saturday, October 17, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 16, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, July 31, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 31, 2015FINAL DISPOSITION PROCESSED
Tuesday, June 30, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 31, 2015REGISTERED-PRINCIPAL REGISTER
Friday, February 6, 2015NOTIFICATION PROCESSED BY IB
Tuesday, January 13, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 13, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 24, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 24, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 9, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 5, 2014ASSIGNED TO LIE
Wednesday, November 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 11, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 8, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 8, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 3, 2014REFUSAL PROCESSED BY IB
Tuesday, August 19, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 19, 2014REFUSAL PROCESSED BY MPU
Tuesday, August 19, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 18, 2014NON-FINAL ACTION WRITTEN
Friday, August 15, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, July 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 25, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 24, 2014SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

rydapt system preparations pharmaceutical disorders anti prevention treatment infective antibiotics ocular